Odactra Market Report 2026

Odactra Market Overview

• The Odactra market growth in the historic period has been driven by increasing prevalence of allergic rhinitis, growing awareness of immunotherapy benefits • Market expansion is supported by growing adoption of preventive allergy care, expansion of pediatric and adolescent allergy treatment • Growth Driver: Rising Prevalence Of Allergic Diseases Propels Growth Of The Market • Market Trend: Advancements In Allergy Immunotherapy Tablets For Enhanced Patient Compliance And Outcomes • North America was the largest region in 2025.

What Is Covered Under Odactra Market?

Odactra is an allergy immunotherapy treatment for allergic rhinitis triggered by dust mites. It works by gradually desensitizing the immune system to dust mite allergens, reducing symptoms such as sneezing, runny nose, and itchy eyes. Odactra aims to provide long-term relief by modifying the immune response to allergens over time. The main types of indications for odactra are house dust mite-induced allergic rhinitis and allergic conjunctivitis. House dust mite-induced allergic rhinitis is an allergic reaction characterized by nasal inflammation, sneezing, itching, and congestion triggered by exposure to dust mites. It is used for various age groups, such as adults (18-65 years), adolescents (12-17 years), and children (5-11 years), and is distributed through several distribution channels, including retail pharmacies, online pharmacies, and hospital pharmacies.

What Is The Odactra Market Growth Forecast?

The growth in the forecast period can be attributed to growing adoption of preventive allergy care, expansion of pediatric and adolescent allergy treatment, rising demand for convenient home-administered therapies, increasing focus on immune tolerance development, continued innovation in allergen-based biologics. Major trends in the forecast period include increasing adoption of allergen immunotherapy tablets, rising focus on long-term disease-modifying allergy treatments, expansion of home-based allergy management, growing demand for non-injection immunotherapy options, enhanced patient adherence programs.

Global Odactra Market Segmentation

1) By Indication: House Dust Mite-Induced Allergic Rhinitis, Allergic Conjunctivitis 2) By Age Group: Adults (18-65 Years), Adolescents (12-17 Years), Children (5-11 Years) 3) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospital Pharmacies

What Are The Drivers Of The Odactra Market?

The rise in the prevalence of allergic diseases is expected to propel the growth of the odactra market going forward. Allergic diseases are conditions caused by an abnormal immune response to typically harmless allergens. The rise in allergic diseases is attributed to factors such as environmental changes, increased exposure to allergens, urbanization, and modifications in lifestyle and diet. Odactra uses allergen-specific immunotherapy to gradually expose the body to dust mite allergens, desensitizing the immune system. This reduces allergic reactions, alleviates symptoms, and offers long-term relief for those with dust mite allergies. For instance, in April 2024, according to Allergy UK, a UK-based charity dedicated to supporting individuals affected by allergies in the United Kingdom, over five million individuals require specialized care for severe allergies, and by 2026, it is projected that at least one in two people in Europe will be affected by allergies. Therefore, the rise in the prevalence of allergic diseases is driving the growth of the odactra industry. The rise in the number of hospitals is expected to fuel the growth of the odactra market going forward. A hospital is a healthcare facility providing treatment and care for patients with illnesses or injuries, including emergency care, surgery, and specialized medical services. The rise in the number of hospitals is driven by increasing healthcare demands, population growth, advancements in medical technology, and greater investments in healthcare infrastructure. The increase in healthcare facilities, such as hospitals, will lead people to gain access to allergy treatments. The expansion of hospitals offering specialized care, including immunotherapy for dust mite-induced allergic rhinitis, will drive greater demand for medications such as Odactra. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals in 2023, representing a 0.591% increase from 6,093 hospitals in 2022. Therefore, the rise in the number of hospitals is driving the growth of the odactra industry.

Key Players In The Global Odactra Market

Major companies operating in the odactra market are ALK Abello A/s

Global Odactra Market Trends and Insights

Major companies operating in the odactra market are focusing on developing innovative solutions, such as advanced sublingual allergy immunotherapy tablets, to meet the rising demand for improved patient compliance, non-invasive treatment options, and long-term management of allergen-driven conditions. Allergy immunotherapy tablets deliver controlled doses of specific allergens orally to gradually desensitize the immune system, offering a more convenient and patient-friendly alternative to traditional allergy injections that require frequent clinic visits. For instance, in January 2023, ALK-Abelló, a Denmark-based research-driven pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved ODACTRA (House Dust Mite Allergen Extract) tablets for sublingual use in adolescents aged 12–17. This expanded approval allows ODACTRA to treat house dust mite-induced allergic rhinitis, with or without conjunctivitis, in individuals aged 12–65. ODACTRA serves as immunotherapy for confirmed HDM allergies but is not intended for immediate symptom relief.

Regional Insights

North America was the largest region in the odactra market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Odactra Market?

The odactra market consists of sales of tablets, allergy testing kits, sublingual immunotherapy (SLIT) delivery systems, and patient adherence tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Odactra Market Report 2026?

The odactra market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the odactra industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.